Osaic Holdings’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.5K | Sell |
5,000
-9,000
| -64% | -$17.1K | ﹤0.01% | 5800 |
|
|
2025
Q1 | $26.9K | Buy |
14,000
+7,550
| +117% | +$14.5K | ﹤0.01% | 5120 |
|
|
2024
Q4 | $12.3K | Buy |
6,450
+2,000
| +45% | +$3.8K | ﹤0.01% | 5599 |
|
|
2024
Q3 | $5.87K | Sell |
4,450
-103
| -2% | -$136 | ﹤0.01% | 6019 |
|
|
2024
Q2 | $4.64K | Buy |
4,553
+2,814
| +162% | +$2.87K | ﹤0.01% | 6100 |
|
|
2024
Q1 | $3.18K | Buy |
1,739
+1,000
| +135% | +$1.83K | ﹤0.01% | 6156 |
|
|
2023
Q4 | $916 | Hold |
739
| – | – | ﹤0.01% | 6632 |
|
|
2023
Q3 | $842 | Hold |
739
| – | – | ﹤0.01% | 6717 |
|
|
2023
Q2 | $676 | Hold |
739
| – | – | ﹤0.01% | 6835 |
|
|
2023
Q1 | $414 | Hold |
739
| – | – | ﹤0.01% | 7036 |
|
|
2022
Q4 | $0 | Sell |
739
-224
| -23% | – | ﹤0.01% | 7061 |
|
|
2022
Q3 | $0 | Hold |
963
| – | – | ﹤0.01% | 7108 |
|
|
2022
Q2 | $0 | Hold |
963
| – | – | ﹤0.01% | 7166 |
|
|
2022
Q1 | $1K | Hold |
963
| – | – | ﹤0.01% | 6824 |
|
|
2021
Q4 | $3K | Hold |
963
| – | – | ﹤0.01% | 6717 |
|
|
2021
Q3 | $3K | Sell |
963
-12,093
| -93% | -$37.7K | ﹤0.01% | 6671 |
|
|
2021
Q2 | $49K | Hold |
13,056
| – | – | ﹤0.01% | 5044 |
|
|
2021
Q1 | $45K | Buy |
13,056
+100
| +0.8% | +$345 | ﹤0.01% | 4933 |
|
|
2020
Q4 | $36K | Buy |
12,956
+11,294
| +680% | +$31.4K | ﹤0.01% | 4754 |
|
|
2020
Q3 | $4K | Sell |
1,662
-2,247
| -57% | -$5.41K | ﹤0.01% | 5571 |
|
|
2020
Q2 | $53K | Sell |
3,909
-7,970
| -67% | -$108K | ﹤0.01% | 4134 |
|
|
2020
Q1 | $90K | Buy |
+11,879
| New | +$90K | ﹤0.01% | 3538 |
|